Selecta Biosciences' Dr. Carsten Brunn on Gene Therapy with AAV Vectors
Cleopatrabobb
20 min
Knowledge
Description
<p>Selecta Biosciences' President and CEO Dr. Carsten Brunn details the company's ImmTOR platform, which can mitigate unwanted immune responses that cause immune-related toxicities that impose significant treatment challenges with current therapies.</p>
Uploader
alice.wave
Episodes
1
Selecta Biosciences' Dr. Carsten Brunn on Gene Therapy with AAV Vectors
Cleopatrabobb